The Benefit of Benralizumab Monoclonal Antibody Treatment for Severe Eosinophilic Asthma in a Case Series (Pulmonology Clinic Târgu Mureș, Romania)
Authors
Nimród László
Clinic of Pneumology, Emergency County Clinical Hospital, Târgu Mureș, Romania
Hédy Katalin Sárközy
“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania
Cristina Alexandra Man
man_cristina_alexandra@yahoo.com
Clinic of Pneumology, Emergency County Clinical Hospital, Târgu Mureș, Romania
Edith Simona Ianoși
“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania
Botond Mátyás
“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania
Bianca Emilia Ciurba
Clinic of Pneumology, Emergency County Clinical Hospital, Târgu Mureș, Romania
Corina Mărginean
Clinic of Pneumology, Emergency County Clinical Hospital, Târgu Mureș, Romania
Gabriela Jimborean
gabriela.jimborean275@gmail.com
“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Târgu Mureș, Romania
Language: English
Page range: 157 - 161
Submitted on: Sep 4, 2021
Accepted on: Sep 11, 2021
Published on: Oct 14, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2021 Nimród László, Hédy Katalin Sárközy, Cristina Alexandra Man, Edith Simona Ianoși, Botond Mátyás, Bianca Emilia Ciurba, Corina Mărginean, Gabriela Jimborean, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.